Perrigo (NYSE: PRGO) is a publicly listed company headquartered in Dublin, Ireland that owns 3 consumer brands across 2 categories, and has 1 recorded transaction.[1]
Perrigo was founded in Michigan in 1887 and built its business on making store-brand versions of over-the-counter medicines, so its products are sold under supermarket and pharmacy labels rather than its own name. It has more recently bought consumer brands to sit alongside that business.
brands owned
2
categories
1
acquisitions recorded · 1 since 2015
0
divestitures recorded
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Full-screen interactive tree →
Perrigo bought the branded over-the-counter rights to Prevacid 24HR from GlaxoSmithKline for $61.5 million in cash, capitalising $61.7 million including closing costs as a brand intangible and amortising it over twenty years. What changed hands was the right to sell the brand over the counter rather than the underlying drug, which is how most of Perrigo's branded portfolio has been assembled.
Headlines link to the original publisher. Brandtree does not reproduce article text.
Perrigo owns 3 consumer brands tracked here, including Compeed, Prevacid 24HR and Steripod.
Yes. Perrigo is headquartered in Dublin, Ireland and was founded in 1887.
Perrigo is a publicly listed company owned by its shareholders; it trades as PRGO on the NYSE.
The most recent completed acquisition recorded here is Prevacid 24HR on 29 November 2019.
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.